Medically reviewed by Doru Paul, MD Key Takeaways A JAK2 mutation can make your body produce too many blood cells.  JAK2 ...

Q: My friend says his uncle is being treated for a disease where he has too much blood and he gets "bloodletting’" every other day, like in the Middle Ages. Is there really such a thing, or is he ...

DEAR DR. ROACH: My husband (age 71) received a diagnosis of polycythemia vera a few years ago. I understand this variety of polycythemia isn’t caused by smoking, but we know that smoking does make it ...

Ruxolitinib improves hematocrit control and treatment response in polycythemia vera compared to best available therapy. Patients on ruxolitinib show better Myeloproliferative Neoplasms-Symptom ...

Myeloproliferative neoplasms are blood cancers that cause excess production of blood cells from myeloid stem cells. Common types include chronic myeloid leukemia (CML), polycythemia vera, essential ...

Polycythemia Vera (PV) is a slow-growing cancer of the blood. The cancer is characterized by an overproduction of blood cells within the bone marrow. Too many blood cells causes the blood to thicken.

The blood you don’t need could be exactly what someone else is praying for. It sounds inconceivable, yet for patients requiring frequent therapeutic phlebotomy—blood removal as treatment—this blood is ...

Dr Gerds explores the pros and cons of the present treatment approach for PV. Aaron Gerds, MD, MS: To date for the MPNs [myeloproliferative neoplasms] and polycythemia vera [PV], the only treatment ...

Rusfertide showed a 77% clinical response rate in polycythemia vera patients, significantly higher than the 33% with placebo. The drug reduced phlebotomy frequency, with 0.5 per patient in the ...

You are able to gift 5 more articles this month. Anyone can access the link you share with no account required. Learn more. DEAR DR. ROACH: My husband (age 71) received a diagnosis of polycythemia ...